| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 17.505 | 77.360 | 122.932 | 108.140 |
| Total Income - EUR | - | - | - | - | - | - | 17.505 | 77.360 | 122.932 | 108.140 |
| Total Expenses - EUR | - | - | - | - | - | - | 32.506 | 65.740 | 88.677 | 89.937 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -15.001 | 11.620 | 34.255 | 18.203 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -15.004 | 10.848 | 33.051 | 16.297 |
| Employees | - | - | - | - | - | - | 4 | 5 | 6 | 5 |
Check the financial reports for the company - Paumaryeva Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 0 | 12.662 | 21.386 | 20.910 |
| Current Assets | - | - | - | - | - | - | 4.394 | 12.117 | 17.535 | 33.008 |
| Inventories | - | - | - | - | - | - | 2.799 | 3.725 | 0 | 411 |
| Receivables | - | - | - | - | - | - | 0 | 2.510 | 2.934 | 482 |
| Cash | - | - | - | - | - | - | 1.595 | 5.882 | 14.601 | 32.114 |
| Shareholders Funds | - | - | - | - | - | - | -14.964 | -4.162 | 28.901 | 44.202 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | - | - | 19.358 | 28.941 | 10.020 | 9.715 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8730 - 8730" | |||||||||
| CAEN Financial Year |
8730
|
|||||||||
Comments - Paumaryeva Med S.r.l.